RBX2660 is a microbiota-based investigational product for fecal microbiota transplantation proposed to treat recurrent Clostridium difficile infection. It is derived from fresh stool from multiple donors; both donors and stool samples are methodically screened. Pooled stool samples are commercially prepared under good manufacturing processes. RBX2660 is packaged in ready-to-use enemas.
If you have a Hayes login, click here to view the full report on the Knowledge Center.